Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Mallinckrodt
Moodys
Johnson and Johnson
AstraZeneca

Last Updated: October 21, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR BUSPAR

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Buspar

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00174226 Treatment of Adult ADHD With Atomoxetine or Atomoxetine and Buspar Completed Pfizer Phase 2 2004-11-01 Determine if there is a difference in treatment response for adults with ADHD who are treated with Strattera versus those treated with a combination of Strattera and buspirone
NCT00178971 Serotonin 1A Agonists and Cognition in Schizophrenia Completed National Alliance for Research on Schizophrenia and Depression Phase 3 2003-01-01 Examines cognitive functioning in patients with schizophrenia or schizoaffective disorder who have been treated with antipsychotic medications. Patients will be assigned to take active medication (Buspar)or placebo along with their prescribed antispycotic medication for six weeks. Patients' memory and problem-solving ability will be tested before and after medication.
NCT00178971 Serotonin 1A Agonists and Cognition in Schizophrenia Completed Vanderbilt University Medical Center Phase 3 2003-01-01 Examines cognitive functioning in patients with schizophrenia or schizoaffective disorder who have been treated with antipsychotic medications. Patients will be assigned to take active medication (Buspar)or placebo along with their prescribed antispycotic medication for six weeks. Patients' memory and problem-solving ability will be tested before and after medication.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Buspar

Condition Name

Condition Name for Buspar
Intervention Trials
Healthy 2
Schizophrenia 1
Attention Deficit Disorder With Hyperactivity 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Buspar
Intervention Trials
Disease 3
Spinal Cord Injuries 2
Psychotic Disorders 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Buspar

Trials by Country

Trials by Country for Buspar
Location Trials
United States 22
Canada 3
Korea, Republic of 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Buspar
Location Trials
Maryland 2
Massachusetts 2
North Dakota 2
North Carolina 2
Texas 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Buspar

Clinical Trial Phase

Clinical Trial Phase for Buspar
Clinical Trial Phase Trials
Phase 4 3
Phase 3 1
Phase 2 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Buspar
Clinical Trial Phase Trials
Completed 8
Recruiting 4
Not yet recruiting 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Buspar

Sponsor Name

Sponsor Name for Buspar
Sponsor Trials
Par Pharmaceutical, Inc. 2
Phoenix International Life Sciences, Inc. 2
Teva Pharmaceuticals USA 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Buspar
Sponsor Trials
Other 12
Industry 7
NIH 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Harvard Business School
Express Scripts
Medtronic
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.